Bumitama Agri (SGX:P8Z)'s 1H21 headline/ core PATMI beat our/consensus expectations on higher-than-expected FFB output. 2H21 earnings growth will be mainly driven by better CPO ASPs in the absence of forward sales, and lower export taxes.
Following our EPS upgrade, we maintain our BUY call on Bumitama Agri with a higher target price of S$0.93 on unchanged 12x FY22 PER, its 5-year mean (previously S$0.65 on 12x FY21 PER) as we roll forward our valuation year.
Bumitama Agri trades at single-digit PER with attractive dividend yields of above 6.0%. It has a dividend policy to pay out up to 40% of recurring profits.
Bumitama Agri reported 1H21 headline PATMI of IDR484b (+10% y-o-y). Adjusted for FX loss, 1H21 core PATMI of IDR569b (+9% y-o-y) met 57%/54% of our/ consensus full-year estimates. The better-than-expected 1H21 PATMI was mainly due to strong FFB nucleus output recovery (+27% y-o-y) which more than offset lower CPO ASP achieved of Rp8,201/kg (-2% y-o-y).
The CPO ASP achieved was 20% lower than our estimated market price of Rp10,314/kg. This was due to ~200,000t or 70% of its 1H21 nucleus output forward sales earlier at lower ASPs (net of export taxes).
As for fertiliser, Bumitama Agri managed to apply just ~45% of full-year plan (1H20: ~45%). It also enjoyed lower-than-usual effective tax rate at 22%.
Raising Its Growth Guidance for 2021
Despite 27% y-o-y 1H:2H output ratio will be 50:50 (historically 45:55) as it experienced a mini-peak in 2Q21 (Figs.2-3).
Forward Sales Mostly Delivered in 1H21
Bumitama Agri has immaterial Bumitama Agri announced an interim dividend of S$0.0045 (ex date: 8 Sep).
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....